Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933 M. Abdellah Alaoui JamaliMing-biao YinYoucef M. Rustum Drug Accumulation, DNA Damage, Tiapamil Analog, RO11-2933, Doxorubicin, Cytotoxicity Pages: 77 - 83
Evaluation of N-(5-indanylsulfonyl)-N′-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcoma Peter J. HoughtonJanet A. HoughtonGerald B. Grindey Xenografts, Sulfonyl Urea, Cytotoxicity Pages: 84 - 88
In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines Min-Jian XuDavid S. AlbertsYun Liu Cisplatin, Cyclophosphamide, Doxorubicin, Gynecologic Cancer Cells Pages: 89 - 94
Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone T. ZaccheoE. Di Salle Aromatase Inhibitor, FCE 24304, DMBA-Induced Mammary Tumor, Rats Pages: 95 - 98
The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo Gwi E. KimChang W. Song Fluosol-DA, Carbogen Breathing, Antitumor Effects, Cyclophosphamide Pages: 99 - 102
Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine M. Eileen DolanGregory L. LarkinAnthony E. Pegg O6-Alkylguanine, O6-Methylguanine, Alkylating Agents, Xenografts Pages: 103 - 108
Nephrotoxicity of 5-(N-phenylcarboxamido)-2-thiobarbituric acid in the Fischer 344 rat Yoshio NakagawaRobert A. Kramer Merbarone, Nephrotoxicity, Fischer 344 Rat Pages: 109 - 113
Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines Maria Teresa ParodiLuigi VaresioGian Paolo Tonini Cisplatin, Morphological Change, Neuroblastoma Cells Pages: 114 - 116
Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic mice Roslyn E. WallaceDolores LindhF. E. Durr Ara-AC, Athymic Mice, Xenografts, Human Tumors Pages: 117 - 123
Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients Antonio C. BuzaidDavid S. AlbertsHarinder S. Garewal Dipyridamole, Fluorodeoxyuridine, Cytotoxicity Pages: 124 - 130
Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer D. J. TH. WagenerQ. G. C. M. van HoeselS. P. Strijk 5-Fluorouracil, Adriamycin, Cisplatin, Radiation, Pancreatic Cancer Pages: 131 - 134
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone Takashi YoshidaShinobu NakamuraHideyo Natori Aclacinomycin Combination Therapy, Refractory Non-Hodgkin's Lymphoma Pages: 135 - 138
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution M. J. LindJ. M. MargisonP. M. Wilkinson Ifosfamide, Drug Distribution. Pharmacokinetics, Bronchial Carcinoma Pages: 139 - 142
[131I]-Metaiodobenzylguanidine in the treatment of metastatic neuroblastoma Thomas KlingebielJörn TreunerDietrich Niethammer [131I]-Metaidobenzylguanidine, Neuroblastoma, Children Pages: 143 - 148
